I agree that this site is using cookies. You can find further informations here.
X
Howard, JF
121  results:
Search for persons X
?
1

P.053 Concomitant corticosteroid use in ravulizumab-treated..:

Nicolle, MW ; Annane, D ; Meisel, A...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  51 (2024)  s1 - p. S30-S30 , 2024
Link: https://doi.org/10.1017/..
 
?
2

His resynchronization therapy produces more physiological v..:

Cheng, TC ; Arnold, ADA ; Chow, JC...
EP Europace.  23 (2021)  Supplement_3 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
3

P.026 Response to eculizumab in patients with myasthenia gr..:

Genge, A ; Jacob, S ; Murai, H...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  46 (2019)  s1 - p. S20-S21 , 2019
Link: https://doi.org/10.1017/..
 
?
4

P.023 Eculizumab shows consistent improvements across muscl..:

Larue, S ; Mantegazza, R ; Fujita, KP..
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  46 (2019)  s1 - p. S19-S20 , 2019
Link: https://doi.org/10.1017/..
 
?
5

A.01 Relieving the burden of myasthenia gravis: eculizumab ..:

Siddiqi, Z ; Howard, JF ; Jacob, S...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  46 (2019)  s1 - p. S8 , 2019
Link: https://doi.org/10.1017/..
 
?
6

P.057 Achievement of minimal symptom expression in acetylch..:

Bril, V ; Muppidi, S ; Howard Jr., JF...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  51 (2024)  s1 - p. S31-S31 , 2024
Link: https://doi.org/10.1017/..
 
?
7

P.055 Corticosteroid dose tapering in patients with general..:

Genge, A ; Hewamadduma, C ; Freimer, M...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  51 (2024)  s1 - p. S31-S31 , 2024
Link: https://doi.org/10.1017/..
 
?
8

P.054 Long-term safety and efficacy of zilucoplan in myasth..:

Genge, A ; Howard Jr., JF ; Freimer, M...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  51 (2024)  s1 - p. S30-S31 , 2024
Link: https://doi.org/10.1017/..
 
?
9

P.045 Safety profile overview of Efgartigimod Clinical Tria..:

Bril, V ; Behin, A ; Gwathmey, K...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  50 (2023)  s2 - p. S70-S70 , 2023
Link: https://doi.org/10.1017/..
 
?
10

P.044 Efficacy, safety, and tolerability of efgartigimod in..:

Bril, V ; Vu, T ; Karam, C...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  50 (2023)  s2 - p. S70-S70 , 2023
Link: https://doi.org/10.1017/..
 
?
11

P.040 Long-term efficacy and safety of ravulizumab in adult..:

Vu, T ; Meisel, A ; Mantegazza, R...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  50 (2023)  s2 - p. S68-S69 , 2023
Link: https://doi.org/10.1017/..
 
?
12

P.034 Minimal symptom expression following treatment with e..:

Siddiqi, Z ; Howard Jr, JF ; Bril, V...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  50 (2023)  s2 - p. S67-S67 , 2023
Link: https://doi.org/10.1017/..
 
?
13

P.043 Long-term safety, tolerability, and efficacy of efgar..:

Genge, A ; Pasnoor, M ; Bril, V...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  50 (2023)  s2 - p. S69-S69 , 2023
Link: https://doi.org/10.1017/..
 
?
14

Ravulizumab in Myasthenia Gravis: A Review of the Current E..:

Vu T ; Wiendl H ; Katsuno M..
https://www.dovepress.com/ravulizumab-in-myasthenia-gravis-a-review-of-the-current-evidence-peer-reviewed-fulltext-article-NDT.  , 2023
Link: https://doaj.org/article..
 
?
15

0389 USE OF A CLOSED-LOOP ACOUSTIC STIMULATION NEUROTECHNOL..:

Tegeler, CL ; Howard, LJ ; Schmidt, KD...
Sleep.  40 (2017)  suppl_1 - p. A145-A145 , 2017
Link: https://doi.org/10.1093/..
 
1-15